Heterozygosity for the Non-Deletional O2 Allele Does Not Cause Discrepancies in Automated Blood Donor ABO Grouping.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 957-957 ◽  
Author(s):  
Mark H. Yazer ◽  
Jonathan McGuirt ◽  
Åsa Hellberg ◽  
Bahram Hosseini-Maaf ◽  
Annika Hult ◽  
...  

Abstract In the ABO blood group system any allele which does not give rise to A or B antigen expression is an O allele. The most common O alleles, O1 (O01) and O1v (O02) encode enzymatically inactive truncated proteins due to a single nucleotide polymorphism (SNP) compared to the consensus A1 allele, 261delG. Other O alleles containing the consensus nucleotide at residue 261 have been identified. The most common of these non-deletional O alleles is O2 (O03). It contains other SNPs which render the resulting protein non-functional. The most significant SNP is 802G>A (G268R); the arginine residue blocks the donor sugar’s access to the active site preventing its transfer. Recently O2 alleles were proposed to be the most common cause of ABO discrepancies (anti-A lacking or weakened in plasma despite apparent group O phenotype) in automated blood grouping (Transfusion2005;45:1331). Other clinical or biochemical reports have suggested that O2 may produce small amounts of A antigen on the RBC surface (Transfusion2005;45:70, 2005;45:359, J Biol Chem2005;280:525). To establish the effect of the O2 allele on automated ABO typing we extracted DNA from 562 randomly selected group O RBC units that were available for transfusion. Automated forward and reverse ABO grouping was performed on an Olympus PK7231 using A1 and B cells for reverse typing (Pittsburgh) and the IBG Multisampler Plato 3000 SI system using A1, A2 and B cells (Lund). A PCR-RFLP assay (Vox Sang 1995;69:242) involving amplification of exon 6 of the ABO gene followed by cleavage with KpnI to detect the presence of the 261delG SNP was performed and 34/562 (6%) of these units were heterozygous for a deletional and a non-deletional O allele. All 34 of these donors demonstrated an identical digestion pattern with BstEII which cleaves exon 6 in the presence of the consensus sequence at residue 261, confirming their heterozygosity for a non-deletional O allele. Allele-specific PCR to detect the O2-specific 802G>A polymorphism was performed on 32 of these donors for which additional DNA was available; the O2 allele was uniformly detected along with either an O1 or O1v allele. No homozygous O2O2 donors were identified. A sensitive flow cytometric analysis of the RBCs from 7 donors with the O2 allele was performed using monoclonal anti-A (ES-15) and a PE-labelled rat-anti-mouse kappa Ig secondary antibody. None of these RBCs demonstrated fluorescence levels in significant excess of the control O (O1O1) cells whilst A antigen on group B cells was demonstrable. Manual immediate spin and gel card forward typing was performed on these donors using a variety of murine monoclonal, polyclonal and experimental anti-A reagents; no A antigen was detected on their RBCs. Adsorption-elution studies were performed on the RBCs of 3 donors heterozygous for O2 using human-source polyclonal anti-A but no A antigen was detected. All 34 group O RBC units were transfused to group O recipients without reported hemolytic reactions. Our results suggest that in its heterozygous state the O2 allele does not necessarily induce ABO discrepancies in automated testing. Transfusing group O RBCs from donors with an O2 allele to recipients with anti-A did not result in reports of symptoms associated with hemolytic events in the recipients.

1996 ◽  
Vol 75 (05) ◽  
pp. 757-759 ◽  
Author(s):  
Rainer Blasczyk ◽  
Markus Ritter ◽  
Christian Thiede ◽  
Jenny Wehling ◽  
Günter Hintz ◽  
...  

SummaryResistance to activated protein C is the most common hereditary cause for thrombosis and significantly linked to factor V Leiden. In this study, primers were designed to identify the factor V mutation by allele-specific PCR amplification. 126 patients with thromboembolic events were analysed using this technique, PCR-RFLP and direct sequencing. The concordance between these techniques was 100%. In 27 patients a heterozygous factor VGln506 mutation was detected, whereas one patient with recurrent thromboembolism was homozygous for the point mutation. Due to its time- and cost-saving features allele-specific amplification should be considered for screening of factor VGln506.


2003 ◽  
Vol 7 (4) ◽  
pp. 277-281 ◽  
Author(s):  
Ruliang Xu ◽  
Shuji Ogino ◽  
Va Lip ◽  
Hong Fang ◽  
Bai-Lin Wu

Author(s):  
Rahim NEMATI ◽  
Aliasghar BAHARI ◽  
Pezhman MAHMOODI ◽  
Alireza SAZMAND

Background: Resistance to benzimidazole (BZ) compounds is common in Teladorsagia circumcincta populations in sheep and goats worldwide. Given the importance of anthelmintic resistance and shortage of information on single nucleotide polymorphisms (SNPs) in this prevalent nematode in Iran, this study was conducted. Methods: From June to September 2016, abomasa of 139 sheep of different sexes and ages in Amol City slaughterhouse, northern Iran were examined for isolation of nematodes. Totally 45 male T. circumcincta confirmed by both microscopical and nested-PCR-RFLP methods were included in this study. Susceptibility or resistance of each single T. circumcincta worm to benzimidazoles was assessed using allele-specific PCR. Results: Frequency of genotypes in the present study were 33.33% heterozygote BZ and 66.67% BZ homozygote sensitive. No homozygote resistant worm was found. Conclusion: Resistance against BZs in T. circumcincta of sheep has occurred at a low prevalence in the north of Iran. However, mutated genes might get dominant under drug selection in future. Hence, periodic investigations for early detection of mutated alleles in nematode populations using accurate and sensitive molecular methods such as PCR-RFLP is recommended.


Author(s):  
Fatemeh Sheikhsofla ◽  
Behzad Poopak ◽  
Sajjad Firuzyar ◽  
Fatemeh Roudbari ◽  
Mojtaba Ghadiany

Background: KRAS and BRAF genes are the biomarkers in Colorectal Cancer (CRC) which play prognostic and predictive roles in CRC treatment. Nowadays, the selection of rapid and available methods for studying KRAS and BRAF mutations in anti-EGFR therapy of patients suffering from CRC plays a significant role. In this study, the mutations of these two oncogenes were evaluated by different methods. Methods: This study was performed on 50 Formalin-Fixed Paraffin-Embedded (FFPE) tissue blocks of patients diagnosed with colorectal cancer. After DNA extraction, KRAS and BRAF gene mutations were evaluated using reverse dot blot, and results were compared with PCR-RFLP and allele-specific PCR for KRAS and BRAF mutations, respectively. Results: KRAS gene mutations were detected in 42% of patients, of which 30% were in codon 12 region, and 12% in codon 13. The most frequent mutations of KRAS were related to G12D  and 10% of patients had BRAF mutated genes. The type of KRAS gene mutations could be evaluated by reverse dot blot method. In general, the results of PCR-RFLP and allele-specific PCR were similar to the findings by reverse dot blot method.  Conclusion: These findings suggest that PCR-RFLP and allele-specific PCR methods are suitable for screening the presence of the mutations in KRAS and BRAF oncogenes. In fact, another method with more sensitivity is needed for a more accurate assessment to determine the type of mutations. Due to higher speed of detection, reduced Turnaround Time (TAT), and possible role of some KRAS point mutations in overall survival, reverse dot blot analysis seems to be an optimal method.


Planta Medica ◽  
2017 ◽  
Vol 83 (11) ◽  
pp. 946-953 ◽  
Author(s):  
Salvatore Tomasello ◽  
Günther Heubl

AbstractThe fruits of Xanthium sibiricum have been widely used in traditional Chinese medicine for the treatment of nasal sinusitis and headaches. The genus Xanthium (cocklebur) is a taxonomically complex genus. Different taxonomic concepts have been proposed, some including several species, others lumping the different taxa in a few extremely polymorphic species. Due to the morphological similarities between species, the correct authentication of X. sibiricum is very difficult. Therefore, we established a polymerase chain reaction-restriction fragment length polymorphism method and diagnostic PCR based on nuclear internal transcribed spacer and chloroplast trnQ-rps16 barcodes to differentiate X. sibirium from related species.Results from the phylogenetic analyses based on sequence information from four marker regions (plastidal psbA-trnH and trnQ-rps16 and nuclear ITS and D35) support those taxonomic concepts accepting a reduced number of species, as four to five major clades are revealed in the phylogenetic reconstructions. X. sibiricum, together with some accessions from closely related taxa, is always supported as monophyletic, constituting a well-defined genetic entity. Allele-specific primer pairs for ITS and trnQ-rps16 were designed to amplify diagnostic products from the genomic DNA of X. sibiricum. Specific PCR in combination with digestion using the restriction enzyme MseI allowed for the identification of X. sibiricum by producing specific restriction patterns. The results demonstrate that the applied techniques provide effective and accurate authentication of X. sibiricum.


Author(s):  
S. Nath ◽  
S. Pal ◽  
S. Mandal ◽  
S. Jadhao ◽  
M. Sankar ◽  
...  

Background: Benzimidazole resistance is one of the key problem in small ruminant production. A rapid, truthful and responsive system is required for detection benzimidazole resistance so that proper regulatory measure can be applied. Allele specific PCR is one of the tools to understand the mechanism and origin of benzimidazole resistance. Methods: A total 198 larvae of Haemonchus contortus were isolated from goats of Chhattisgarh region, central India were genotyped by allele specific polymerase chain reaction (AS-PCR). Faecal samples of goats were collected from three Government farms and adjoining field goats and were subjected for faecal culture, separately. DNA of third stage larva was used for nested PCR for amplification of β- tubulin gene. Restriction Fragment Length Polymorphism (RFLP) was applied on nested PCR product for species identification with RsaI enzyme. AS-PCR was applied on the nested-PCR product to know the genotypic and allelic frequency. Result: The nested PCR amplified product showed approximately 820 bp in all cases and PCR-RFLP revealed 462 bp, 211 bp and 147 bp fragments, which confirmed the species as H. Contortus. Frequency of resistant allele ('r') was 49.7% and 50.3% for susceptible allele ('S '). Frequency of homozygous resistant (rr), heterozygous susceptible (rS) and homozygous susceptible (SS) genotype were 33.83 per cent, 31.81 per cent and 34.34 per cent, respectively. The frequency of homozygous resistant (rr) genotype was low (19.61%) in field compare to farm (48.96%) indicating refugia in field region.


2015 ◽  
pp. 97-102
Author(s):  
A. V. Voropayeva ◽  
O. V. Karpenko ◽  
E. V. Bredikhina ◽  
T. P. Krivun ◽  
O. V. Osipkina ◽  
...  

Objective: to study the role of IL-1β (C511T), IL-2 (T330G), IL-13 (C1111T) gene polymorphism in the development of stomach diseases in Belarusian population. Material and methods. The study included 194 patients diagnosed with «chronic gastritis» and 68 patients diagnosedwith «cancer of the stomach». To determine polymorphisms of IL-2 (T330G), IL-13 (C-1111T) and IL-1β (C511T) genes, we used the method of allele-specific PCR (AS-PCR) and PCR detection of the length of restriction fragments (PCR-RFLP). Results . By the loci of IL-2 (T330G), IL-13 (C1111T), IL-1b (S511T) we revealed the correlation with oncopathology depending on the status of infection by various strains of H. pylori. Conclusion . The use of the revealed association of cytokine gene polymorphism with the development of the diseases makes it possible to select genetic components that determine the sensitivityof the population to the development of stomach diseases depending on H. pylori infection in Belarusian population.


2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Dayse Maria Vasconcelos de Deus ◽  
Karina Araújo Lugo ◽  
Maria Tereza Cartaxo Muniz

Interleukin 10 (IL10) is a pleiotropic cytokine that stimulates various hematopoietic cells. The tumor necrosis factor alpha (TNFα) is a cytokine that may influence the transcriptional activity induced by glucocorticoids. This study examined the impact of TNFα (G308A) and IL10 (G1082A) polymorphisms at promoter regions in relation to the overall survival of 105 children (0≤18 years) with acute lymphoblastic leukemia (ALL) for a period of 126 months, treated according to the protocol GBTLI99. The G1082A and G308A polymorphisms were identified by allele-specific PCR and PCR-RFLP, respectively. Patients with IL10AA genotype had a higher death ratio (44%, P=0.0089). Patients with both IL10AA and TNFAA genotypes showed the worst survival when compared with the IL10GG and TNFGA genotypes (P=0.0043). The results of this study revealed a lower survival among patients with IL10AA genotype and the concomitant occurrence of IL10AA and TNFAA genotypes.


2015 ◽  
Vol 94 (4) ◽  
pp. 201
Author(s):  
Bruno Ferraz-de-Souza

<p>Endocrinology is one of several medical specialities that have been gradually transformed by a deeper understanding of the molecular bases of disorders. Genetic testing with the purposes of defining a precise molecular diagnosis has increasingly gained space in the routine assessment of patients with endocrinopathies, and the advent of massive parallel sequencing (MPS) is boosting the incorporation of molecular information in the clinic. The main benefit of genetic testing is diagnostic precision, resulting in improved and individualized care for patients and family members, and better disease prevention. However, genetic tests are not infallible and may bear several potential risks, being thus indicated when clinical suspicion is strong and the benefit of determining a molecular diagnosis is unambiguous. In this review, these evolving concepts and current indications for molecular diagnosis in endocrinology will be explored. Molecular tools will be revised and contextualised, including those aimed at identifying changes in gene dosage (karyotpe, FISH, MLPA, aCGH, SNParray) or in the DNA nucleotide sequence (allele-specific PCR, RFLP, Sanger sequencing, MPS or NGS). Finally, matters surrounding the complex attribution of biologically relevant functional impact to identified DNA variants will be explored, together with the challenges brought by high throughput molecular analysis. These are exciting times for molecular endocrinology, and hopefully soon a translation to multiple benefits for patients will be self-evident.</p>


Sign in / Sign up

Export Citation Format

Share Document